查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1553597

标靶 DNA RNA定序市场规模、份额、趋势分析报告：按产品、按工作流程、按应用、按技术、按类型、按最终用途、按细分市场预测，2024-2030 年

Targeted DNA RNA Sequencing Market Size, Share & Trends Analysis Report By Product (NGS), By Workflow (Pre-sequencing), By Application, By Technology, By Type, By End Use, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格
简介目录

标靶 DNA RNA定序市场成长与趋势：

预计2030年，全球标靶DNA RNA定序市场规模将达345.6亿美元，2024年至2030年复合年增长率为19.4%。

标靶定序已成为生命科学研究中的重要技术，它能够对感兴趣的特定领域进行研究，同时保持定序成本和资料复杂性可控。

这种方法透过允许评估基因内的特定转录区或已知持有与疾病发展相关的突变的特定基因来增加定序的深度。一些研究计划已经采用了这种技术，以避免资讯浪费和额外成本，并仅研究相关基因。此类计划的数量持续增长，从而推动了市场的发展。

解决定向标靶序列捕获方法缺陷的技术创新预计将在预测期内提高该技术的使用率。此外，较低的序列成本和改进的资讯学使标靶化方法比以往任何时候都更容易在临床实践中使用。

靶向 DNA RNA定序市场报告亮点

  • NGS 及其辅助通讯协定的快速发展正在促进这一领域的成长。
  • 在所有基于NGS的标靶化方法中，EXOME-seq所占比重最大。
  • 这是因为，虽然它只占基因组的不到 2%，但它包含 85% 的已知疾病相关变异。
  • 总体标靶方法分为预测定序、序列测定和资料分析。
  • 定序，最重要的一步，占比最大。
  • 这个领域彻底改变了各种生命科学应用，包括人类生物医学研究、植物和动物科学以及药物发现。
  • 其中，人类生物医学研究估计是该领域最大的应用，因为它经常用于研究疾病的发病机制。
  • 根据样本类型，目标 DNA/RNA定序市场分为 DNA-seq 和 RNA-seq。
  • 据估计，DNA定序将比相应领域产生更高的收益。这是由于存在多种 DNA 定序产品和试剂套件。
  • 从最终用途来看，由于大学和其他学术中心基于 seq 的计划的增加，学术研究估计是最大的部分。
  • 由于对基因测试和生物资讯工具的核准存在有效的法规，北美占据了最大的份额。
  • 此外，美国已被证实安装的定序仪数量最多，占据了北美地区市场的很大份额。
  • 亚太地区预计将成为成长最快的区域市场。
  • 亚洲国家基于基因组的计划数量的增加和 GDP 的持续增长预计将推动亚太市场的发展。

目录

第一章调查方法与范围

第 2 章执行摘要

第 3 章 标靶 DNA RNA定序序市场变数、趋势与范围

  • 市场介绍/系统展望
  • 市场规模及成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 标靶 DNA RNA定序市场分析工具
    • 波特的分析
    • PESTEL分析

第四章 标靶 DNA RNA定序序市场：技术估算与趋势分析

  • 细分仪表板
  • 标靶 DNA RNA定序市场：2023 年和 2030 年技术变化分析
  • 下一代种子
  • 其他的

第五章 标靶 DNA RNA定序市场：依工作流程进行估算与趋势分析

  • 细分仪表板
  • 标靶 DNA RNA定序市场：工作流程变化分析，2023 年和 2030 年
  • 预测定序
  • 定序
  • 资料分析

第六章 标靶 DNA RNA定序市场：依应用估算与趋势分析

  • 细分仪表板
  • 标靶 DNA RNA定序市场：2023 年和 2030 年应用变化分析
  • 人类生物医学研究
  • 植物和动物科学
  • 药物发现
  • 其他的

第七章 靶向 DNA RNA定序市场：按类型估计和趋势分析

  • 细分仪表板
  • 标靶 DNA RNA定序市场：类型变异分析，2023 年和 2030 年
  • 基于DNA的标靶定序
  • 基于RNA的标靶定序

第 8 章 标靶 DNA RNA定序市场：最终用途的估计与趋势分析

  • 细分仪表板
  • 标靶 DNA RNA定序市场：最终用途变异分析，2023 年和 2030 年
  • 学术研究
  • 医院/诊所
  • 製药和生物技术公司
  • 其他的

第九章 标靶DNA RNA定序序市场：区域估计与趋势分析

  • 2023 年及 2030 年按地区分類的标靶 DNA RNA定序市场占有率
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 科威特

第10章竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 企业热力图分析
  • 公司简介
    • Illumina
    • F. Hoffman-La Roche Ltd.
    • QIAGEN
    • Thermo Fisher Scientific, Inc.
    • Bio-Rad Laboratories, Inc.
    • Oxford Nanopore Technologies
    • PierianDx
    • Genomatix GmbH
    • DNASTAR, Inc.
    • Perkin Elmer, Inc.
简介目录
Product Code: GVR-1-68038-681-3

Targeted DNA RNA Sequencing Market Growth & Trends:

The global targeted DNA RNA sequencing market size is expected to reach USD 34.56 billion in 2030 and is projected to grow at a CAGR of 19.4% from 2024 to 2030. Targeted Sequencing has emerged as a key technology in life science research by enabling examination of a specific region of interest while keeping the seq. cost as well as the complexity of data under manageable limits.

This approach enhances sequencing depth by allowing the evaluation of specific coding regions within genes or specific genes, which are known to harbor mutations for disease pathogenesis. Several research projects have employed this technology to avoid wastage of information and extra cost and study only relevant genes. The number of such projects continues to grow, consequently driving the market.

Innovations to address the pitfalls of targeted enrichment methods are anticipated to enhance the usage rate of this technology throughout the forecast period. Moreover, with a decrease in seq-cost and improvement in informatics, targeted methods have become more accessible for use in clinical settings than ever.

Targeted DNA RNA Sequencing Market Report Highlights:

  • Rapid advancements in NGS and its ancillary protocols can be attributed to the growth of this segment.
  • Out of all the NGS-based targeted methods, exome-seq held the largest share.
  • This can be attributed to the fact that though it accounts for less than 2% of the genome, it contains 85% of the known disease-relevant variants.
  • Entire targeted approach is broken down into presequencing, sequence determination, and data analysis.
  • Being the most crucial step, sequencing accounted for the largest share.
  • This space has revolutionized various applications of life sciences, including human biomedical research, plant & animal sciences, drug discovery, and others.
  • Out of all, human biomedical research is estimated to be the largest application of this space due to its high usage in studying disease pathogenesis.
  • The targeted DNA/RNA sequencing market is bifurcated into DNA-seq and RNA-seq, based on the sample type.
  • DNA-sequencing has been estimated to generate higher revenue over its counterpart segment. This can be attributed to the presence of a wide range of products and kits for DNA-seq.
  • As per end use, academic research is estimated to be the largest segment owing to the increase in seq-based projects at universities and other academic centers.
  • North America held the largest share owing to the presence of effective regulations pertaining to approval of genetic tests and bioinformatics tools.
  • Moreover, the U.S. is observed to have the highest number of installed sequencers, which in turn, has contributed to the large share of the North America regional market.
  • Asia Pacific is expected to emerge as the fastest growing regional market.
  • Rise in genome-based projects coupled with constant GDP growth in Asian countries is expected to drive the Asia Pacific market.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Targeted DNA RNA Sequencing Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Targeted DNA RNA Sequencing Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Targeted DNA RNA Sequencing Market: Technology Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Targeted DNA RNA Sequencing Market: Technology Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. NGS
    • 4.3.1. NGS Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Method Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.2.1. Exome Sequencing
        • 4.3.2.1.1. Exome Sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.2.2. Enrichment Sequencing
        • 4.3.2.2.1. Enrichment Sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.2.3. Amplicon Sequencing
        • 4.3.2.3.1. Amplicon Sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.2.4. Others
        • 4.3.2.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Application Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.3.1. Cancer Gene Sequencing
      • 4.3.3.2. Cancer Gene Sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.3.3. Inherited Disease Screening
      • 4.3.3.4. Inherited Disease Screening Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.3.5. Drug Development
      • 4.3.3.6. Drug Development Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.3.7. Forensic Genomics
      • 4.3.3.8. Forensic Genomics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.3.9. 16S Ribosomal RNA (rRNA)
      • 4.3.3.10. 16S Ribosomal RNA (rRNA) Sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Others
    • 4.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Targeted DNA RNA Sequencing Market: Workflow Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Targeted DNA RNA Sequencing Market: Workflow Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Pre-sequencing
    • 5.3.1. Pre-sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Sequencing
    • 5.4.1. Sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Data Analysis
    • 5.5.1. Data Analysis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Targeted DNA RNA Sequencing Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Targeted DNA RNA Sequencing Market: Application Movement Analysis, 2023 & 2030 (USD Million)
  • 6.3. Human Biomedical Research
    • 6.3.1. Human Biomedical Research Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Plant & Animal Sciences
    • 6.4.1. Plant & Animal Sciences Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Drug Discovery
    • 6.5.1. Drug Discovery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Targeted DNA RNA Sequencing Market: Type Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Targeted DNA RNA Sequencing Market: Type Movement Analysis, 2023 & 2030 (USD Million)
  • 7.3. DNA Based Targeted Sequencing
    • 7.3.1. DNA Based Targeted Sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. RNA Based Targeted Sequencing
    • 7.4.1. RNA Based Targeted Sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Targeted DNA RNA Sequencing Market: End Use Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. Targeted DNA RNA Sequencing Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
  • 8.3. Academic Research
    • 8.3.1. Academic Research Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4. Hospitals & Clinics
    • 8.4.1. Hospitals & Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Pharma & Biotech Entities
    • 8.5.1. Pharma & Biotech Entities Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Others
    • 8.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Targeted DNA RNA Sequencing Market: Regional Estimates & Trend Analysis

  • 9.1. Targeted DNA RNA Sequencing Market Share, By Region, 2023 & 2030 (USD Million)
  • 9.2. North America
    • 9.2.1. North America Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.2.2. U.S.
      • 9.2.2.1. U.S. Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.2.3. Canada
      • 9.2.3.1. Canada Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.2.4. Mexico
      • 9.2.4.1. Mexico Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.3. Europe
    • 9.3.1. Europe Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.2. UK
      • 9.3.2.1. UK Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.3. Germany
      • 9.3.3.1. Germany Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.4. France
      • 9.3.4.1. France Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.5. Italy
      • 9.3.5.1. Italy Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.6. Spain
      • 9.3.6.1. Spain Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.7. Denmark
      • 9.3.7.1. Denmark Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.8. Sweden
      • 9.3.8.1. Sweden Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.9. Norway
      • 9.3.9.1. Norway Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.4. Asia Pacific
    • 9.4.1. Asia Pacific Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.2. China
      • 9.4.2.1. China Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.3. Japan
      • 9.4.3.1. Japan Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.4. India
      • 9.4.4.1. India Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.5. South Korea
      • 9.4.5.1. South Korea Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.6. Australia
      • 9.4.6.1. Australia Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.7. Thailand
      • 9.4.7.1. Thailand Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5. Latin America
    • 9.5.1. Latin America Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.2. Brazil
      • 9.5.2.1. Brazil Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.3. Argentina
      • 9.5.3.1. Argentina Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Middle East and Africa Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.2. Saudi Arabia
      • 9.6.2.1. Saudi Arabia Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.3. UAE
      • 9.6.3.1. UAE Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.4. South Africa
      • 9.6.4.1. South Africa Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.5. Kuwait
      • 9.6.5.1. Kuwait Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis by Key Market Participants
  • 10.2. Company Categorization
  • 10.3. Company Heat Map Analysis
  • 10.4. Company Profiles
    • 10.4.1. Illumina
      • 10.4.1.1. Participant's Overview
      • 10.4.1.2. Financial Performance
      • 10.4.1.3. Product Benchmarking
      • 10.4.1.4. Recent Developments/Strategic Initiatives
    • 10.4.2. F. Hoffman-La Roche Ltd.
      • 10.4.2.1. Participant's Overview
      • 10.4.2.2. Financial Performance
      • 10.4.2.3. Product Benchmarking
      • 10.4.2.4. Recent Developments/Strategic Initiatives
    • 10.4.3. QIAGEN
      • 10.4.3.1. Participant's Overview
      • 10.4.3.2. Financial Performance
      • 10.4.3.3. Product Benchmarking
      • 10.4.3.4. Recent Developments/Strategic Initiatives
    • 10.4.4. Thermo Fisher Scientific, Inc.
      • 10.4.4.1. Participant's Overview
      • 10.4.4.2. Financial Performance
      • 10.4.4.3. Product Benchmarking
      • 10.4.4.4. Recent Developments/Strategic Initiatives
    • 10.4.5. Bio-Rad Laboratories, Inc.
      • 10.4.5.1. Participant's Overview
      • 10.4.5.2. Financial Performance
      • 10.4.5.3. Product Benchmarking
      • 10.4.5.4. Recent Developments/ Strategic Initiatives
    • 10.4.6. Oxford Nanopore Technologies
      • 10.4.6.1. Participant's Overview
      • 10.4.6.2. Financial Performance
      • 10.4.6.3. Product Benchmarking
      • 10.4.6.4. Recent Developments/Strategic Initiatives
    • 10.4.7. PierianDx
      • 10.4.7.1. Participant's Overview
      • 10.4.7.2. Financial Performance
      • 10.4.7.3. Product Benchmarking
      • 10.4.7.4. Recent Developments/Strategic Initiatives
    • 10.4.8. Genomatix GmbH
      • 10.4.8.1. Participant's Overview
      • 10.4.8.2. Financial Performance
      • 10.4.8.3. Product Benchmarking
      • 10.4.8.4. Recent Developments/Strategic Initiatives
    • 10.4.9. DNASTAR, Inc.
      • 10.4.9.1. Participant's Overview
      • 10.4.9.2. Financial Performance
      • 10.4.9.3. Product Benchmarking
      • 10.4.9.4. Recent Developments/Strategic Initiatives
    • 10.4.10. Perkin Elmer, Inc.
      • 10.4.10.1. Participant's Overview
      • 10.4.10.2. Financial Performance
      • 10.4.10.3. Product Benchmarking
      • 10.4.10.4. Recent Developments/Strategic Initiatives